The company said while a third shot of its original coronavirus vaccine increased neutralising antibodies against the variant at the lower dose, their levels declined six months after the booster dose was administered...
The U.S. FDA has expanded the emergency use authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 Vaccine to include individuals 18 years and older.
The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Krishna Ella, Chairman and Managing Director, Bharat Biotech, said yesterday...